TECHNETIUM TC

Technetium Tc Adverse Events Reported to the FDA Over Time

How are Technetium Tc adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Technetium Tc, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Technetium Tc is flagged as the suspect drug causing the adverse event.

Most Common Technetium Tc Adverse Events Reported to the FDA

What are the most common Technetium Tc adverse events reported to the FDA?

Drug Ineffective	166 (34.44%)
Pruritus	9 (1.87%)
Headache	8 (1.66%)
Nausea	8 (1.66%)
Swollen Tongue	8 (1.66%)
Dyspnoea	7 (1.45%)
Rash	7 (1.45%)
Urticaria	7 (1.45%)
Visual Impairment	6 (1.24%)
Convulsion	5 (1.04%)
Diarrhoea	5 (1.04%)
	Show More
Injection Site Erythema	5 (1.04%)
Malaise	5 (1.04%)
Oedema Peripheral	5 (1.04%)
Pain	5 (1.04%)
Pyrexia	5 (1.04%)
Ageusia	4 (.83%)
Asthenia	4 (.83%)
Dysgeusia	4 (.83%)
Erythema	4 (.83%)
Flushing	4 (.83%)
Hypoaesthesia	4 (.83%)
Paraesthesia Oral	4 (.83%)
Rash Macular	4 (.83%)
Renal Failure Acute	4 (.83%)
Sepsis	4 (.83%)
Tachycardia	4 (.83%)
Vomiting	4 (.83%)
Gait Disturbance	3 (.62%)
Hyperhidrosis	3 (.62%)
Hypoaesthesia Oral	3 (.62%)
Hypotension	3 (.62%)
Injection Site Haematoma	3 (.62%)
Injection Site Inflammation	3 (.62%)
Injection Site Swelling	3 (.62%)
Injection Site Warmth	3 (.62%)
Lip Swelling	3 (.62%)
Loss Of Consciousness	3 (.62%)
Product Quality Issue	3 (.62%)
Stridor	3 (.62%)
Tremor	3 (.62%)
Angina Pectoris	2 (.41%)
Bacterial Infection	2 (.41%)
Blister	2 (.41%)
Blood Pressure Decreased	2 (.41%)
Bradycardia	2 (.41%)
Cerebrovascular Accident	2 (.41%)
Chest Discomfort	2 (.41%)
Chest Pain	2 (.41%)
Chills	2 (.41%)
Confusional State	2 (.41%)
Dizziness	2 (.41%)
Eye Swelling	2 (.41%)
Hypersensitivity	2 (.41%)
Injection Site Rash	2 (.41%)
Movement Disorder	2 (.41%)
Muscle Disorder	2 (.41%)
Oxygen Saturation Decreased	2 (.41%)
Unevaluable Event	2 (.41%)
Unresponsive To Stimuli	2 (.41%)
Vertigo	2 (.41%)
Abdominal Discomfort	1 (.21%)
Abdominal Pain	1 (.21%)
Abdominal Pain Upper	1 (.21%)
Accidental Exposure	1 (.21%)
Accidental Needle Stick	1 (.21%)
Acute Generalised Exanthematous Pus...	1 (.21%)
Anaphylactic Shock	1 (.21%)
Anaphylactoid Reaction	1 (.21%)
Angioedema	1 (.21%)
Anorexia	1 (.21%)
Anxiety	1 (.21%)
Arthralgia	1 (.21%)
Blepharitis	1 (.21%)
Burning Sensation	1 (.21%)
Caesarean Section	1 (.21%)
Cardiac Arrest	1 (.21%)
Circulatory Collapse	1 (.21%)
Cold Sweat	1 (.21%)
Condition Aggravated	1 (.21%)
Contrast Media Reaction	1 (.21%)
Diabetic Retinopathy	1 (.21%)
Drug Administration Error	1 (.21%)
Drug Exposure During Pregnancy	1 (.21%)
Drug Hypersensitivity	1 (.21%)
Dry Skin	1 (.21%)
Dysarthria	1 (.21%)
Ear Discomfort	1 (.21%)
Ear Haemorrhage	1 (.21%)
Ear Infection	1 (.21%)
Eating Disorder	1 (.21%)
Empyema	1 (.21%)
Endocarditis Staphylococcal	1 (.21%)
Extravasation	1 (.21%)
Eye Infection	1 (.21%)
Eyelid Oedema	1 (.21%)
Fatigue	1 (.21%)
Feeling Abnormal	1 (.21%)
Feeling Hot	1 (.21%)
Furuncle	1 (.21%)
General Physical Health Deteriorati...	1 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Technetium Tc, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Technetium Tc is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Technetium Tc

What are the most common Technetium Tc adverse events reported to the FDA?

Therapeutic And Nontherapeutic Effe...	166 (34.44%)
Epidermal And Dermal Conditions	33 (6.85%)
Administration Site Reactions	25 (5.19%)
Neurological	23 (4.77%)
Gastrointestinal Signs	15 (3.11%)
Infections - Pathogen Unspecified	15 (3.11%)
Oral Soft Tissue Conditions	11 (2.28%)
Angiedema And Urticaria	9 (1.87%)
Tongue Conditions	9 (1.87%)
Cardiac Arrhythmias	8 (1.66%)
Headaches	8 (1.66%)
	Show More
Vision	8 (1.66%)
Respiratory	7 (1.45%)
Movement Disorders	6 (1.24%)
Musculoskeletal And Connective Tiss...	6 (1.24%)
Allergic Conditions	5 (1.04%)
Body Temperature Conditions	5 (1.04%)
Gastrointestinal Motility And Defec...	5 (1.04%)
Muscle	5 (1.04%)
Seizures	5 (1.04%)
Skin Appendage Conditions	5 (1.04%)
Decreased And Nonspecific Blood Pre...	4 (.83%)
Procedural And Device Related Injur...	4 (.83%)
Product Quality Issues	4 (.83%)
Renal Disorders	4 (.83%)
Upper Respiratory Tract Disorders	4 (.83%)
Vascular	4 (.83%)
Bacterial Infectious	3 (.62%)
Cardiac And Vascular Investigations	3 (.62%)
Coronary Artery	3 (.62%)
Inner Ear And Viiith Cranial Nerve	3 (.62%)
Medication Errors	3 (.62%)
Aural	2 (.41%)
Central Nervous System Vascular	2 (.41%)
Deliria	2 (.41%)
Eye	2 (.41%)
Metabolic, Nutritional And Blood Ga...	2 (.41%)
Ocular Infections, Irritations And ...	2 (.41%)
Retina, Choroid And Vitreous Hemorr...	2 (.41%)
Anxiety Disorders	1 (.21%)
Appetite And General Nutritional	1 (.21%)
Bone Disorders	1 (.21%)
Bronchial Disorders	1 (.21%)
Chemical Injury And Poisoning	1 (.21%)
Eating Disorders	1 (.21%)
Fatal Outcomes	1 (.21%)
Joint	1 (.21%)
Lifestyle Issues	1 (.21%)
Obstetric And Gynecological Therape...	1 (.21%)
Therapeutic Procedures And Supporti...	1 (.21%)
Tissue	1 (.21%)
Urinary Tract Signs	1 (.21%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Technetium Tc, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Technetium Tc is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.